D.E. Shaw & Co’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

D.E. Shaw & Co’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$98K	–	6063
2021 Q4	$98K	Hold	10,000	–	–	﹤0.01%	5067
2021 Q3	$340K	Hold	10,000	–	–	﹤0.01%	4291
2021 Q2	$366K	Hold	10,000	–	–	﹤0.01%	4179
2021 Q1	$448K	Hold	10,000	–	–	﹤0.01%	3555
2020 Q4	$571K	Hold	10,000	–	–	﹤0.01%	3324
2020 Q3	$513K	Hold	10,000	–	–	﹤0.01%	3222
2020 Q2	$597K	Hold	10,000	–	–	﹤0.01%	3244
2020 Q1	$412K	Hold	10,000	–	–	﹤0.01%	3298
2019 Q4	$622K	Buy	+10,000	New	+$475K	﹤0.01%	3273

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

D.E. Shaw & Co's DCPH Position: Q2 2024 in Review

D.E. Shaw & Co sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 506,384 shares — an estimated $7.97M sold.

D.E. Shaw & Co first reported a position in DCPH in Q2 2018 and held it in 16 quarters. The position peaked at $16.4M in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

D.E. Shaw & Co reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
D.E. Shaw & Co sold 506,384 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $7.97M.
D.E. Shaw & Co first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
D.E. Shaw & Co's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $16.4M in Q4 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.